Pricing Log in Create free account

Matinas Biopharma Holdings, Inc. (MTNB) vs Virax Biolabs Group Limited (VRAX)

Matinas Biopharma Holdings, Inc. and Virax Biolabs Group Limited are both Biotechnology companies. Matinas Biopharma Holdings, Inc. and Virax Biolabs Group Limited are of similar size ($2.4M and $2.2M). Across the 10 metrics below, Virax Biolabs Group Limited leads on 6 and Matinas Biopharma Holdings, Inc. on 4.

Valuation

Metric MTNB VRAX Biotechnology median
P/E n/m n/m 8.50
P/S 0.24 n/m 9.71
P/B 0.56 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.86 0.64
EV/Sales 0.05 n/m 9.21
Earnings yield (348.48%) (367.59%) (33.15%)
Free cash flow yield (602.45%) 0.00% (25.50%)

Profitability

Metric MTNB VRAX Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (154.28%) 0.00% (56.36%)
Return on assets (98.53%) 0.00% (48.04%)
Return on invested capital (419.27%) 0.00% 0.00%

Growth

Metric MTNB VRAX Biotechnology median
Revenue growth (TTM) 2,139.41% — 6.02%
EPS growth (last fiscal year) 62.08% 68.79% 30.26%
Revenue growth, 5-year CAGR 55.69% (36.88%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MTNB VRAX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.85 9.97 4.72
Net debt to EBITDA 0.62 1.08 0.96

Dividend

Metric MTNB VRAX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MTNB VRAX Biotechnology median
Market cap 2.37m 2.18m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack